Shilpa Medicare Ltd

Shilpa Medicare Ltd is rated Buy by MarketsMOJO, with this rating last updated on 06 August 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 09 September 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.

With a remarkable 123.65% gain over the past year, Shilpa Medicare Ltd surged to a fresh 52-week high of Rs 980.65 on 7 Sep 2026, defying the broader market’s subdued tone and showcasing a powerful technical momentum that has captivated market watchers.

With a remarkable 132.05% gain over the past year, Shilpa Medicare Ltd surged to a fresh 52-week high of Rs 974.9 on 4 Sep 2026, showcasing a powerful momentum that has captivated market attention amid a mixed broader market backdrop.

Surging past its previous peaks, Shilpa Medicare Ltd touched a fresh 52-week high of Rs 962.05 on 3 Sep 2026, marking a remarkable rally from its low of Rs 260 just a year ago. This impressive price momentum is underpinned by a confluence of bullish technical indicators and sustained upward trends across multiple timeframes.

Shilpa Medicare Ltd experienced a notable intraday decline on 1 Sep 2026, touching a low of Rs 876.95, down 7.69% from previous levels. The stock underperformed its sector and broader market indices despite recent gains, reflecting immediate price pressures and a shift in market sentiment.

Surging from a 52-week low of Rs 260 to a fresh peak of Rs 952.2 on 1 Sep 2026, Shilpa Medicare Ltd has more than tripled in value over the past year, showcasing remarkable price momentum despite a broadly subdued market backdrop.

Surging past its previous peaks, Shilpa Medicare Ltd touched a new 52-week high of Rs 921.7 on 31 Aug 2026, marking a remarkable rally that has more than tripled the stock price from its 52-week low of Rs 260. This milestone comes amid a backdrop of strong technical momentum and sustained price appreciation, even as the broader market struggles to find footing.

Shilpa Medicare Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 6 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 August 2026, providing investors with the latest insights into its performance and outlook.

Surging past its previous peaks, Shilpa Medicare Ltd touched a new 52-week high of Rs 875.95 on 27 Aug 2026, marking a remarkable rally from its 52-week low of Rs 260. This impressive price momentum has propelled the stock to outperform its sector and the broader market, despite a subdued Sensex environment.

With a remarkable ascent from Rs 260 to Rs 868.75 over the past year, Shilpa Medicare Ltd has more than doubled its share price, culminating in a fresh 52-week high on 26 Aug 2026. This milestone reflects a powerful alignment of technical indicators and sustained price momentum that has propelled the stock well ahead of broader market trends.

Shilpa Medicare Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, reached a significant milestone on 25 Aug 2026 by hitting a new 52-week high of Rs.868.1, reflecting strong momentum and robust performance in recent trading sessions.

A 101% stock return in one year. A 102.8% growth in net profit over the same period. The near parity between these two figures suggests that Shilpa Medicare Ltd’s recent rally is largely supported by fundamental earnings growth rather than purely valuation expansion. This article analyses the drivers behind the multibagger performance and examines whether the fundamentals justify the market’s enthusiasm.

Surging past its previous peaks, Shilpa Medicare Ltd touched a new 52-week high of Rs 833.9 on 20 Aug 2026, marking a remarkable 94.13% gain over the past year. This milestone comes amid a backdrop of strong technical momentum and sustained outperformance versus the broader market indices.

Shilpa Medicare Ltd is rated Buy by MarketsMOJO, with this rating last updated on 6 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 August 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.

Surging to a new 52-week high of Rs 825.5 on 17 Aug 2026, Shilpa Medicare Ltd has demonstrated remarkable price momentum, outperforming the broader market with a 79.8% gain over the past year against the Sensex’s decline of 3.57%. This milestone caps a sustained rally driven by a confluence of bullish technical indicators and robust quarterly earnings growth.

Surging past its previous peaks, Shilpa Medicare Ltd reached a new 52-week high of Rs 822.4 on 11 Jun 2026, propelled by a sustained rally that has delivered nearly 36% returns over the past eight trading sessions.

Surging past its previous peaks, Shilpa Medicare Ltd touched a fresh 52-week high of Rs 792.75 on 10 Jun 2026, marking a remarkable rally of 88.07% over the past year. This milestone comes amid a sustained uptrend supported by a confluence of bullish technical indicators and strong price momentum.